Skip to main content
MAIA Biotechnology, Inc. logo

MAIA Biotechnology, Inc. — Investor Relations & Filings

Ticker · MAIA ISIN · US5526411021 US Manufacturing
Filings indexed 456 across all filing types
Latest filing 2023-05-22 Director's Dealing
Country US United States of America
Listing US MAIA

About MAIA Biotechnology, Inc.

https://maiabiotech.com/

MAIA Biotechnology, Inc. is a clinical-stage immuno-oncology company focused on the development and commercialization of targeted therapies for cancer. The company develops potential first-in-class drugs with novel mechanisms of action, specializing in telomere-targeting agents. Its therapeutic approach utilizes immunotherapies designed to target telomeres in cancer cells. The company's pipeline products are currently under clinical investigation.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2023-05-22 English
PRIMARY DOCUMENT
Director's Dealing
2023-05-17 English
10-Q
Interim / Quarterly Report Q1 2023
2023-05-08 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 8, 2023, by MAIA Biotechnology, Inc. It announces the results of operations for the quarter ended March 31, 2023, via a press release attached as Exhibit 99.1. The text explicitly states that the information is "furnished" and not "filed," indicating it is an announcement rather than the full financial report itself. The document is a current report providing an update on quarterly results, typical of an Earnings Release. The length (6375 characters) and content focus on announcing quarterly financial results align with the Earnings Release category rather than a full Interim/Quarterly Report, which would contain detailed financial statements and analysis. Therefore, the appropriate classification is Earnings Release (ER).
2023-05-08 English
PRIMARY DOCUMENT
Director's Dealing
2023-05-01 English
PRIMARY DOCUMENT
Director's Dealing
2023-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.